Oct 24, 2019
2:00pm - 3:00pm
Join Jesper Lau, Vice President of Research Chemistry at Novo Nordisk A/S to learn why the discovery of Semaglutide is a fantastic example of on how technology and biologic understanding have developed a superior peptide for the treatment of diabetes.